Shema Oral Liquid Ameliorates the Severity of LPS-Induced COPD via Regulating DNMT1

Shema Oral Liquid Ameliorates the Severity of LPS-Induced COPD via Regulating DNMT1

Background: Chronic obstructive pulmonary disease (COPD) is the most common respiratory disease with high morbidity and mortality. Shema oral liquid (Shema) is a traditional Chinese medicine (TCM) approved for the treatment of respiratory diseases. Clinical applications have shown that Shema has ant...

Full description

Bibliographic Details
Main Authors: Fangbo Zhang, Feifei Guo, Yang Liu, Yi Zhang, Defeng Li, Hongjun Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Pharmacology
Subjects:
chronic obstructive pulmonary disease
shema oral liquid
network pharmacology
quantitative proteomics
lipopolysaccharide
DNMT1
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.903593/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.903593/full

Similar Items